Axon regeneration is substantially regulated by gene expression and cytoskeleton remodeling. Here we show that the tumor suppressor protein p53 is required for neurite outgrowth in cultured cells including primary neurons as well as for axonal regeneration in mice. These effects are mediated by two newly identified p53 transcriptional targets, the actin-binding protein Coronin 1b and the GTPase Rab13, both of which associate with the cytoskeleton and regulate neurite outgrowth. We also demonstrate that acetylation of lysine 320 (K320) of p53 is specifically involved in the promotion of neurite outgrowth and in the regulation of the expression of Coronin 1b and Rab13. Thus, in addition to its recognized role in neuronal apoptosis, surprisingly, p53 is required for neurite outgrowth and axonal regeneration, likely through a different post-translational pathway. These observations may suggest a novel therapeutic target for promoting regenerative responses following peripheral or central nervous system injuries.
Introduction
Axonal injuries induce delayed biochemical alterations that may result in either cell death or survival/restoration, including successful target re-innervation (Yakovlev and Faden, 1995; Kalb and Strittmatter, 2000; Dumont et al, 2001; Makwana and Raivich, 2005) . Functional recovery reflects, in part, the number of surviving cells and fiber tracts, the extent of neural plasticity, and the presence of a permissive environment for regeneration. Such processes are orchestrated by time-regulated gene expression changes, with an earlier phase associated with inflammation, extension of axonal damage and cell death, and a later one linked to axon outgrowth and regeneration (Kubo et al, 2002; Bareyre and Schwab, 2003; Di Giovanni et al, 2003 , 2005a Glanzer et al, 2004) .
Some of the genes related to neurite and axon outgrowth and regeneration play a dual role in both cell death and in cell survival following central nervous system (CNS) or peripheral nerve injury (Benowitz and Routtenberg, 1997; Hughes et al, 1999; Emery et al, 2003) . One example of this duality of effects is provided by the transcription factor c-jun, which has been implicated in cell death and nerve degeneration in various models of CNS and peripheral nerve injury, but more recently has also been shown to be required for axonal regeneration following nerve transection (Raivich et al, 2004) .
Another transcription factor with pleiotropic functions is the tumor suppressor protein p53, which serves as a key determinant of cell fate following exposure to a variety of insults (Schuler and Green, 2005; Vousden and Prives, 2005) . p53 functions as a DNA-binding, sequence-specific transcription factor that activates the expression of multiple genes, causing either reversible cell-cycle arrest or apoptosis. The proapoptotic activity of p53 often occurs when cells are exposed to severe genotoxic stress, whereas its effects on cell-cycle arrest may occur after moderate DNA damage, or after nutrient depletion (Bates et al, 1999; Jones et al, 2005) .
The transcriptional activity of p53 is increased in neuronal precursors of the developing mouse brain, whereas it is reduced in cells undergoing terminal differentiation (Rogel et al, 1985; Schmid et al, 1991) . However, high levels of p53 mRNA have also been detected in the developing brain in areas showing little or no apoptosis (Gottlieb et al, 1997; Komarova et al, 1997) , and a percentage of p53-deficient mice exhibit neuronal abnormalities, particularly defects in neural tube closure (Armstrong et al, 1995) . Studies in neuronal-like cells have also suggested that p53 plays a role in cell survival following NGF administration in PC-12 cells, and that the interaction of p53 with neuronal-specific transcription factors, such as Brn-3a, may determine a shift from cell death to neuronal survival (Hudson et al, 2004 (Hudson et al, , 2005 . Thus, because of its dual actions on cell cycle and cell death, p53 plays a versatile role in the regulation of cellular growth and differentiation.
We have recently employed temporal gene expression profiling after experimental spinal cord injury (SCI) in rats (Di Giovanni et al, 2005b) , through which we identified a cluster of temporally correlated genes, including factors known to promote neurite outgrowth and axonal regeneration. This cluster includes the actin-binding protein Coronin 1b, and the GTPase Rab13, which we showed to be required for physiological neurite outgrowth in PC-12 cells and dorsal root ganglion neurons (Di Giovanni et al, 2005b) . The temporally coordinated activation of these genes suggested that their expression might be regulated by a common transcription factor. In this study, we have explored this possibility, and we demonstrate that p53 regulates the expression of both Coronin 1b and Rab13. Moreover, p53 is required for neurite outgrowth and maturation in cultured neurons, as well as for axonal regeneration following facial nerve transection. These activities are mediated by acetylation of p53 at position K320, which we have recently shown to be involved in p53-mediated resumption of proliferation and cell survival.
Results

In silico promoter analysis and experimental evidence identify p53 as a transcription factor for Coronin 1b and Rab13
We recently demonstrated that the actin-binding Coronin 1b and the small GTPase Rab13 are temporally coregulated following experimental SCI during the phase of nerve regeneration and recovery (Di Giovanni et al, 2005b) . Importantly, these genes are also coexpressed with the proneurite outgrowth and proaxonal regeneration protein Gap-43 (growthassociated protein-43) in axons after injury, and are required for the promotion of neurite outgrowth in PC-12 cells as well as in primary neurons (Di Giovanni et al, 2005b) . These findings led us to hypothesize that their expression may be regulated by common transcription factors. In order to verify this hypothesis, we performed an 'in silico' computer-based analysis of the predicted promoters of Rab13 and Coronin 1b genes. We found that rat Coronin 1b and Rab13 have multiple common p53 transcription binding sites (TBS). Significantly, such p53-binding motifs were conserved in both the mouse and human genes, thus implying that they are physiologically relevant ( Figure 1A) .
To assess whether p53 can bind to these promoter regions in vivo and within a chromatin environment, chromatin immunoprecipitation (ChIP) assays were performed. For these experiments, we took advantage of a p53 null cell line (H1299), where the expression of p53 is controlled by a tetracycline-inducible system. As shown ( Figure 1B ), p53 is bound to the 'in silico' predicted TBS of endogenous Coronin 1b and Rab13 in vivo. Moreover, in human embryonic kidney cells (293), in rat pheocromocytoma PC-12 cells, and in the p53-inducible H1299 cells, both messenger RNAs and protein levels of Coronin 1b and Rab13 were coordinately upregulated following p53 expression ( Figures 1C and D) . Indeed, neither Coronin 1b nor Rab13 were expressed in H1299 cells on Coronin 1b and Rab13. DNA sequences and location from the transcription starting site are also reported. MS stands for matrix similarity, and a score between 0.7 and 1 is considered highly significant. p53 matching P-value for the described TBS is highly significant. For details about interpretation of these data see: http://www. in the absence of tetracycline, and overexpression of p53 in 293 or PC-12 cell lines resulted in a marked induction of their levels ( Figure 1D ). Conversely, either a p53-specific RNAi or a p53 dominant-negative construct (p53DN), previously shown to inhibit p53-dependent transcription (Yakovlev et al, 2004) , nearly completely abrogated the expression of these two proteins in response to NGF treatment. Thus, the expression levels of Coronin 1b and Rab13 are regulated by p53.
p53 and its target genes Coronin 1b and Rab13 are expressed sequentially during neurite outgrowth The above results lead to the prediction that a correlation should exist between p53 expression and the levels of Coronin 1b or Rab13 during neurite outgrowth and neuronal maturation. To test this possibility, we used PC-12 cells treated with NGF or rat embryonic primary cortical neurons (RCN) exposed to neuronal medium (B27). NGF mediates neurite outgrowth and cytoskeleton remodeling in PC-12 cells, whereas cultured RCN undergo maturation, neurite elongation, sprouting and expression of postmitotic neuronal-specific proteins in the presence of B27. In PC-12 cells exposed to NGF, we observed an early induction of nuclear p53, which was paralleled by elevations in the expression levels of Coronin 1b and Rab13, as well as of Gap-43 ( Figure  2A and B). The latter is a cytoskeleton-bound protein found in growth cones and commonly used as a marker of neurite outgrowth, maturation and regeneration ( Figure 2A ). The levels of p53 are regulated predominantly at a posttranslational level, via a regulatory feedback with the ubiquitin ligase MDM2. Thus, we examined whether the expression of MDM2 changes during neurite outgrowth. We found that a marked reduction of MDM2 protein levels preceded p53 activation ( Figure 2C ). Such downregulation might explain, at least in part, the observed p53 induction in response to growth factors. In RCN, the expression of p53 peaked in the nuclei 2 days after the addition of growth factors, and this coincided with the time of greatest increase of Coronin 1b, Rab13, and Gap-43 protein levels ( Figure 2D-F) at the cortical cytoskeleton. Therefore, p53 seems to act as a switch to turn on Coronin 1b and Rab13 expression levels in RCN, and its baseline expression levels appear to be sufficient to maintain Coronin 1b and Rab13 protein levels over longer periods of time. Alternatively, p53 post-translational modifications such as acetylation, which might increase the transcriptional activity of p53, as well as other transcription factors, might be involved in the sustained, long-term expression of Coronin 1b and Rab13. Thus, in different experimental systems there is a tight temporal correlation between the pattern of expression of p53 and that of Coronin 1b and Rab13.
p53 is required for neurite outgrowth
To further evaluate the potential role of p53 for neurite outgrowth, we first studied the effects of inhibiting p53 activity with the p53DN construct. The read-outs for these experiments were the NGF-mediated induction of neurite outgrowth in PC12 cells, and neurite outgrowth and maturation in cultured embryonic RCN. Stably transfected p53DN PC12 cells or RCN infected with a p53DN-lentiviral vector were treated with growth factors, and their phenotypes were analyzed. As it can be seen, inhibition of p53 signaling blocked the NGF-mediated increase of Coronin 1b and Rab13 expression ( Figure 3A) . Strikingly, in contrast to naive PC-12 cells, the p53DN-transfected cells did not produce neurites following NGF treatment but, rather, demonstrated neurite length and number similar to that of untreated cells ( Figure 4B and C). Similar results were also obtained by inhibiting p53 expression with a specific siRNA (data not shown). Likewise, expression of the p53DN in RCN markedly reduced the expression of both Coronin 1b and Rab13 ( Figure 4A, Supplementary Figure 1) , and significantly inhibited neurite outgrowth and branching ( Figure 4B and C). Gap-43 levels were also decreased in cells expressing the p53DN construct. Thus, in the absence of p53, RCN cells fail to complete the maturation program in response to growth factors.
To more definitely assess the impact of p53-mediated control of Coronin 1b and Rab13 on neurite outgrowth, a rescue experiment was subsequently performed. In PC-12 cells stably transfected with p53DN, transfection of Coronin 1b and Rab13, which localized at high levels at the cortical cytoskeleton and at the growth cone ( Figure 5A , Supplementary Figure 2) , significantly restored the differentiated phenotype to a similar extent with and without previous administration of NGF, suggesting that NGF signaling is completely blocked in p53DN stably expressing cells and that Coronin 1b and Rab13 act downstream of p53 in such pathway ( Figure 5A and B). These results support the conclusion that p53 is required for neurite outgrowth, and that such effects largely reflect p53-mediated modulation of Coronin 1b and Rab13 expression.
Specific acetylation of p53 at lysine 320 preferentially induces Coronin 1b and Rab13 expression, binds to their promoter elements and promotes neurite outgrowth
The highly undifferentiated human (NT2/D1) teratocarcinoma cells differentiate into several cell types, including neurons, following retinoic acid (RA) administration, and develop neuritic and synaptic networks. Thus, they are a very good model to study the molecular mechanisms of neurite outgrowth (Pleasure et al, 1992) . Importantly, it was shown previously that although p53 transcriptional activity is required for NT2/D1 cellular differentiation, RA treatment induces a paradoxical reduction of p53 total protein levels (Curtin et al, 2001; Curtin and Spinella, 2005) . This observation suggests that specific post-translational modifications may be required to regulate p53 activity, especially in conditions where the total levels of the protein are diminished. We have recently shown that in epithelial cells, specific acetylation of p53 at lysine 320 (K320) favors cell survival, unlike acetylation of lysine 372 (K372), which promotes cell death (Knights et al, 2006) . Therefore, we examined whether specific acetylation events of p53 occur during neuronal maturation and neurite outgrowth. To this end, we first measured total p53 protein levels following RA treatment in NT2-D1 cells. Consistent with previous studies, we found that RA induced indeed a reduction of total p53 levels, which corresponded with the time of expression of the neuronal and neurite outgrowth markers b-3 tubulin and Gap-43. This also coincided with a net increase in the levels of expression of the p53 targets Coronin 1b and Rab13 ( Figure 6A ). Despite the lower p53 levels induced by RA, acetylation of K320 but not of K372 of p53 was markedly increased, and RA treatment also clearly induced the expression levels of the acetyltrans-ferase PCAF, which is known to acetylate p53 at K320 (Knights et al, 2006) .
To test the possibility that acetylation of K320 is specifically responsible for the regulation of the expression levels of Coronin 1b and Rab13, we used a p53 null cell line (H1299) where the expression of native p53 or of p53 acetylation mutants at positions 320 (p53K320Q) and 372 (p53K372Q) was reconstituted with a tetracycline-inducible system. Substitution of lysine (K) for glutamine (Q) mimics the effects of a constitutive acetylation (Knights et al, 2006) , likely because acetylation neutralizes the positive charge of lysine, whereas glutamine recapitulates this effect. The results of these experiments were striking. Indeed, the p53K320Q acetylation mimic strongly induced the expression of Coronin 1b and Rab13, whereas p53K372Q had only a minimal effect ( Figure 6B ). To gain more confidence that truly acetylated p53 at lysine 320 (acetyl-K320 p53) is capable of a direct interaction with the p53-binding sequences contained in the promoter regions of Coronin 1b and Rab13, we performed a ChIP assay in cells expressing native p53. As it can been seen, the comparison of ChIP reactions performed with the antibody recognizing total p53 (FL-393), and the antibody recognizing exclusively p53 populations acetylated at position 320 (anti-acetyl-320), showed that acetylated p53 binds to these promoters with very high affinity. In addition, overexpression of the acetyltransferase PCAF resulted in a net increase in binding of acetylated p53 to these promoters. Thus, collectively, these results demonstrate that p53 populations acetylated at lysine 320 bind to the promoter regions of Coronin 1b and Rab13 ( Figure 6C ), and regulate the expression of these two genes. Then, to explore whether p53K320 is really important for neuronal maturation and neurite outgrowth, NT2-D1 cells were transfected with the plasmid expressing the p53 acetylation mimics p53K320Q or p53K372Q. The expression of Gap-43 and of the p53 target genes Coronin 1b and Rab13 was then examined. Strikingly, we found that only cells transfected with p53K320Q, but not with p53K372Q expressed Gap-43, and displayed increased expression of Coronin 1b and Rab13 ( Figure 7A ). In order to address the specificity of the effect of the p53K320Q mimic, a p53K320R mutant, where lysine was replaced with arginine, was employed in similar experiments and results were compared to cells treated with RA-GFP or transfected with GFP only. Arginine has the same charge as lysine, but it prevents acetylation, and therefore is a useful control for the glutamine substitution (see for example, Knights et al, 2006) . In this case, the expression levels of Coronin 1b and Rab13, while induced by RA, were comparable to control cells transfected with GFP ( Figure 7B ). Thus, these results strongly support the notion that p53 molecules acetylated at position 320 are specifically responsible for the regulation of Coronin 1b and Rab13 during neurite outgrowth.
Finally, to validate the concept that p53 acetylation at lysine 320 plays a role in neurite outgrowth in a model system more relevant to the mammalian CNS, we tested the effects of the mutants p53K320Q and p53K320R in rat primary cortical neurons. Cultured primary neurons were transfected with the vectors expressing these p53 acetylation mutants, and their effect compared to those exerted by GFP. As it can be seen, the p53K320Q mutant was able to increase total neurite length by 40712% (s.d.), and the length of the longest neurite by 31714%, while total number of neurites was not significantly affected ( Figure 8A and B) . In fact, we observed an opposite effect following expression of the p53K320R mutant. This led to a reduction of 31711% of the total average of neurite length, with the length of the longest neurite impaired by 41712%, and only modestly affected the number of neurites by 2278% ( Figure 8A and B).
Overall these data show that acetylated p53 at lysine 320 binds to the Coronin 1b and Rab13 promoter elements and plays an important role in neurite outgrowth in different neuronal cells and signaling pathways. regenerating fibers, was 32.8%71.5 (s.e.) in the axotomized side compared to the control side in WT mice, versus 1471.6% (s.e.) in the p53 null mice ( Figure 9A and B); this difference was highly significant (t-test P-valueo0.0001).
As p53 can play a role in apoptosis and elimination of neurons following axotomy (Kiryu-Seo et al, 2005), we counted the number of surviving facial motor neurons (FMN) at 28 days postaxotomy. This analysis showed about 10% fewer surviving FMN in WT (70.877% (s.e.)) versus p53À/À mice (80.279%) compared to control unoperated side ( Figure 9C ). This difference is not statistically significant, but suggests that there are fewer cells available for target reinnervation in the WT mouse. As the WT shows also more regenerating neurons than the null counterpart, together these data suggest that p53 plays a dual role in the elimination of highly damaged cells and in axon regeneration of surviving neurons. Also, the presence of fewer cells available for target reinnervation in WT magnifies the difference between the number of regenerating neurons in the WT versus p53 null mice following axotomy.
In agreement with our in vitro studies, immunofluorescence experiments in WT mice also showed that the expres- sion of Coronin 1b and Rab13 was clearly induced preferentially in axonal sprouts in regenerating facial nuclei in WT, but not in p53 null mice ( Figure 9D ). Thus, p53 is required for the expression of Coronin1b and Rab13 in axonal sprouts during nerve regeneration.
Discussion
In this study, we have demonstrated that p53 promotes neurite outgrowth in vitro and nerve regeneration in vivo through molecular mechanisms that involve the activation of the actin-binding protein Coronin 1b and the GTPase Rab13. We recently showed that Coronin 1b and Rab13 were coexpressed at neurite tips, in association with the known proplasticity factor Gap-43, after experimental spinal cord trauma as well as in cell culture models of neurite outgrowth. These factors were part of a larger cluster of genes, identified using microarrays methodology, which were highly coordinately regulated after SCI (Di Giovanni et al, 2005b) . A search for potential common regulatory elements within this gene cluster identified the tumor suppressor protein p53 as a potential transcriptional regulator. We demonstrated that p53, a protein implicated in neuronal apoptosis, promotes neurite outgrowth in vitro and axonal regeneration in vivo. Indeed, p53 is required for neurite outgrowth and regeneration: primary neurons and PC-12 cells expressing either dominant-negative forms or siRNA specific for p53 are unable to develop neurites and p53 null mice show impaired nerve regeneration following axotomy. In tissue culture cells, these effects are mediated, at least in part, by p53-dependent transcriptional activation of Coronin 1b and Rab13. The latter proteins both play an important role in cytoskeleton remodeling and have diverse cellular functions. The ability of Coronin 1b to interact with actin and promote its polymerization might underlie its biological actions, as it could favor cellto-cell communications, affect localization of receptors on the cell membrane and facilitate remodeling of the cytoskeleton at the growth cone (De Hostos, 1999; Humphries et al, 2002; Oku et al, 2003; Rybakin and Clemen, 2005) . Rab13, which belongs to the trans-Golgi network, may play a role in synaptic vesicle transport, similar to several other members of Rab family (Tang, 2001) . These activities of Coronin 1b and Rab13 are likely to be important for neurite outgrowth, maturation, and regeneration. The effects of p53 activation in the nervous system, as in other cells, appear to be pleiotropic. Previous work has shown that p53 is capable of modulating complex molecular pathways that potentially lead to neuronal cell death, DNA repair, and differentiation (for a review, see Miller et al, 2000; Oren, 2003; Harms et al, 2004) . Also, a role for p53 in PC-12 cells in survival and cell-cycle arrest following growth factors has been proposed, including Trk-A receptor-and MAPK cascade-dependent p53 activation (Montano, 1997; Poluha et al, 1997; Hughes et al, 2000) . In one report (Hughes et al, 2000) , p53 activity was not associated with neurite outgrowth in PC-12 cells. Nevertheless, these findings are in contradiction with previous reports and our data (Montano, 1997; Poluha et al, 1997) , which showed that p53 activity was actually required for neurite outgrowth. Differences may be due to the use of different mutant p53 proteins and PC-12 cell lines. Also, we were the first to use RNA interference for p53 in neurite outgrowth assays through which we showed that silencing p53 expression blocks NGF-mediated neurite outgrowth in PC-12 cells. Most importantly, in addition to the identification of the novel proneurite outgrowth p53 targets Coronin 1b and Rab13, here we show that specific post-translational modifications of p53 promote neurite outgrowth and that p53 is required for physiological axonal regeneration in vivo.
How does p53 switch among its multiple biological functions? p53 activity is well known to be regulated by multiple post-translational modifications, including phosphorylation and acetylation. The C-terminal segment of p53 is acetylated at different residues by at least two different acetyltransferases, p300/CBP, and PCAF. p300/CBP acetylate lysines at position 370, 372, 373 and 382 of p53, while PCAF acetylates a single residue at position 320 (Avantaggiati et al, 1997; Lill et al 1997; Xu, 2003; Bode and Dong, 2004) .
We recently have found that acetylation at lysine 320 specifically promotes survival and proliferation in epithelial cells, unlike acetylation of lysine 372 that triggers cell death. These different biological outcomes are due to the ability of each acetylation event to influence protein-protein interactions and to re-direct the activity of p53 onto selected sets of promoters that act either in favor of cell survival or by promoting cell death (Knights et al, 2006) . Consistent with the idea that acetylation of K320 serves as a prosurvival signal, we have shown here that acetylation of this residue, but not of lysine 372 of p53, was specifically induced by signals that stimulate neurite outgrowth and preceded neuronal maturation in NT2-D1 cells. Importantly, this acetylation event coincided with an enhancement of the expression levels of PCAF. Similar changes were also observed in PC-12 cells during neurite outgrowth following NGF (data not Overexpression of the acetylation mimicking p53K320Q mutant promotes neurite outgrowth in primary cortical neurons, while the p53K320R mutant inhibits it. (A) Cultured primary rat cortical neurons (E18) were transfected at day 3 for 72 h with either GFP, p53K320Q, or p53K320R mutant plasmid DNAs. Both GFP and immunostaining with anti-human p53 antibodies (Cell Signaling AB1, AB6) were used to detect p53 expression, and to identify nuclear and neurites localization. Both control GFP and the p53 mutant proteins were expressed in the nucleus and along the processes. Experiments were performed using co-transfections with p53 mutants and GFP, which also allow the complete identification of processes along with the use of the neuronal-specific staining for b-3 tubulin. Representative images of transfected neurons show that overexpression of p53K320Q enhances neurite outgrowth, while overexpression of p53K320R impairs it as compared to control GFP-transfected cells. (B) Bar graphs show quantitation of neurite outgrowth measurements following transfections expressed as average percentage values of control GFP-transfected cells (data obtained from three different experiments for about 210 total neurons counted for each condition) (*t-test P-values o0.01).
shown). Significantly, p53 acetylated at lysine 320 was also able to bind to the promoter elements of the target genes Coronin 1b and Rab13 as shown by ChIP assay, and binding was enhanced by the expression of PCAF, which acetylates p53 at K320. This event has a functional implication as the expression of a mutant form of p53 that mimics constitutive acetylation at position 320 (p53K320Q), but not of a form that does not allow acetylation at the same site (p53K320R), was able to increase the levels of both Coronin 1b and Rab13 p53 target proteins and to induce Gap-43 as a marker of neurite outgrowth in NT2-D1 cells. Strikingly, delivery of p53K320Q in cultured primary cortical neurons was able to promote neurite outgrowth, while neurons expressing the p53K320R mutant had impaired neurite development, suggesting a possible dominant-negative effect of this specific mutant. Thus, acetylation of p53 at position 320 is involved in p53-mediated induction of Coronin 1b and Rab13 as well as in promotion of neurite outgrowth.
Furthermore, facial nerve transection experiments performed in WT versus p53 null mice clearly showed that p53 is also required for physiological axon regeneration in vivo. This correlated with the fact that the p53 transcriptional targets Coronin 1b and Rab13 were expressed in axonal sprouts in the facial nuclei following nerve cut only in WT mice. Together, our data strongly argue that the proneurite outgrowth activity of p53, which occurs in tissue culture cells through the activation of Coronin 1b and Rab13, is recapitulated in vivo following nerve transection and are required for axonal regeneration.
In conclusion, our work establishes strong evidence for a novel role of p53 in neurite outgrowth and nerve regeneration and provides the molecular framework for such a function. Modulation of this p53-dependent pathway may provide a novel therapeutic target for facilitating neuroplasticity and neuroregeneration after injuries to central or peripheral nervous system. 
Materials and methods
In silico transcription factor binding site (TFBS) analysis
Sequences of selected genes Coronin 1b and Rab13 were analyzed using the FrameWorker, a part of the complex Genomatix software tool (http://www.genomatix. de/matinspector.html, Munich, Germany) , that allows extracting a common framework of elements from a set of DNA sequences. In our case, these elements were TFBS within predicted promoter regions of the genes, since this tool is designed for the comparative analysis of promoter sequences. This software returns the most complex models that are common to the input sequences (and satisfying the user parameters). All elements that occur in the same order and in a certain distance range in the input sequences are identified, thus providing a model of transcriptional regulation of gene activity. The output is a set of candidate transcription factors ranked by P-values according to their probability of binding to the selected TFBS.
ChIP assays
ChIPs were performed as described elsewhere (Ogawa et al, 2002) . Briefly, 4.5 Â10 7 H1299-WTp53 cells were grown in the absence or presence of tetracycline for 48 h and subsequently exposed to a 1% formaldehyde-PBS solution for 13 min at room temperature. Following cell lysis, extracts were sonicated to shear DNA between the lengths of 300-800 bp. Chromatin solutions were precipitated overnight with rotation using 2 mg of rabbit polyclonal anti-p53 antibody (FL393, Santa Cruz) or rabbit polyclonal anti-lys320-p53 antibody (Upstate). Also, in a set of experiments transfection of fulllength PCAF plasmid DNA expressed from pcDNA vector was performed at the moment of tetracycline induction as described previously (Knights et al, 2006) . On the following day, protein A agarose beads that had been previously blocked with salmon sperm DNA and BSA were added to each reaction to precipitate antibody complexes. The precipitated complexes were washed and then incubated at 651C overnight in parallel with 'input' samples to reverse the crosslinking. DNA was isolated by P:C:I extraction, which was followed by ethanol precipitation in the presence of glycogen. The resulting DNA was then used in ChIP PCR reactions. The primers used for amplification of p53-responsive elements were as follows: WAF1-P21-5 0 -TCA CCA TTC CCC TAC CCC ATG CTG CTC-3 0 , 3 0 -AAG TTT GCA ACC ATG CAC TTG AAT GTG-5 0 ; Coronin 1b-5 0 -GTC ATT CCC ACT CCA TGG AG-3 0 , 3 0 -CTC AGT CCT CTG CTG GTC C-5 0 ; and Rab13-5 0 -CTT CAA GTT GCT GCT GAT CG-3 0 ; 3 0 -GAG AAG GAG GTC ACA GGA G-5 0 . Standard PCR parameters were used with annealing temperatures of 551C for Rab13 and 511C for Coronin 1b and P21. All PCR reactions were run using 35 cycles.
Real-time reverse transcriptase (RT)-PCR
We studied Coronin 1b and Rab13 by real-time PCR using cDNAs extracted from H1299 cell lines controlled by a tetracycline p53-inducible expression system, 8 and 24 h after p53 induction by administration of tetracycline. Fluorophore-labeled LUX primers (forward) and their unlabeled counterparts (reverse) were provided by Invitrogen. LUX primers were designed matching the probe set sequences for human Coronin 1b, and Rab13 and all primers were designed using the software called LUX Designer (Invitrogen, www.invitrogen.com/lux). For more experimental details see online Supplementary data.
Cell cultures
Cell lines. Human epithelial 293, H1299, and pheocromocytoma PC-12 cell lines were grown in Dulbecco's modified medium supplemented with 10% fetal bovine serum, 100 U/ml penicillin, and 100 mg/ml streptomycin (Invitrogen) in a humidified atmosphere of 5% CO 2 in air at 371C. The cultures were maintained in a logarithmic phase by passage every 2-3 days. For more experimental details see online Supplementary data.
Rat primary cortical neurons. Cortical neuronal cultures were derived from rat embryonic cortices as reported previously (Di Giovanni et al, 2005c) . For more experimental details see online Supplementary data.
Clones and transfection/infection experiments
PC-12 cells were stable transfected with pcDNA3 vector expressing dominant-negative forms of p53 as described previously (Yakovlev et al, 2004) . For more experimental details see online Supplementary data.
Construction of replication-incompetent lentiviral vectors was performed using ViraPower expression system (Invitrogen), according to the recommendation of the manufacturer. For more experimental details see online Supplementary data.
Rat Coronin 1b and Rab13 were cloned in a GFP expression vector under the control of a CMV promoter and used for transfection experiments.
Tetracycline-inducible vectors were employed in H1299 cells, and were purchased from Invitrogen. Generation of these cell lines was carried out accordingly to the manufacturer's instructions (Invitrogen). The p53 mutants used for the tetracycline-inducible system and for transfection experiments in NT2-D1 cells and primary cortical neurons were constructed by employing a Pfupolymerase-based, site-directed mutagenesis (Stratagene), followed by cloning of the amplified cDNAs into the pCDNA/TO4 vector (Invitrogen). The primers used for mutagenesis were as follows: p53Q320-5 0 -CCC CAG CCA AAG CAG AAA CCA CTG GAT GGA GAA-3 0 ; p53Q372-5 0 -AGC CAC CTG CAG TCC CAA CAG GGT CAG TCT ACC-3 0 ; p53R320-5 0 -CCC CAG CCA AAG AGG AAA CCA CTC GAG GGA GAA-3 0 , 5 0 -TTC TCC CTC GAG TGG TTT CCT CTT TGG CTG GGG-3 0 . A Flag or GFP-encoding sequence was fused in frame to the N-terminus of p53 for immunodetection of the protein.
Transfection experiments were performed using Lipofectamine 2000 (Invitrogen) for PC-12, 293, and H1299.
Lentiviral constructs were used to infect RCN. Expression of transfected or infected p53DN DNAs was detected by antibodies against the V5-tag, expressed in these expression vectors or by GFP visualization, which represented the tag protein for the corresponding control empty vectors ( Figures 3B, C and 4B, C) .
Neurite outgrowth was evaluated in neurons and PC-12 cells considering the number of neurites per cell, the average neurite length, and the length of the longest neurite per cell. Measurements were conducted in at least three different experiments by two different operators. In between 200 and 300 cells for each experimental condition were counted both in the case of primary neurons and PC-12 cells in the several experiments where neurite measurements were performed (see legends for details). Statistical data analysis reflects the results of the combined experiments. Cells were viewed using a CCD camera and analyzed with the image analysis software AxioVision 3.1 (Zeiss).
RNA interference
For RNA interference experiments for p53, we employed a plasmidbased siRNA system (GeneSuppressor System, Imgenex, IMG-803). For additional experimental details see online Supplementary data.
Antibodies
See online Supplementary data.
Immunoblotting and immunocytochemistry
See online Supplementary data. p53 null mice and facial nerve transection Six-week-old homozygous p53À/Àmice FVB.129S2 (B6)-Trp53 tmltyj , and FVB.129S2 (B6) control mice were obtained from Jacksons laboratories. These animals do not present any known developmental abnormalities, and are completely undistinguishable from WT mice. They feed normally, reproduce properly, and show normal motor activity. Importantly, mice homozygous for the Trp53 tm1Tyj mutation often develop tumors (principally lymphomas and osteosarcoma) by the fifth-sixth month of age and die within a month from the disease onset. Our experiments were performed starting at 6 weeks of age in homozygous p53 null and WT mice. Mice were males, all tumors free throughout the experiments, and were five per group. It is important to note that no adverse reaction to surgery has been reported in the literature, and we did not encounter any abnormalities following facial axotomy. The genotype of p53 null mice was confirmed by Southern blot analysis. Facial nerve transection was performed as previously described (Raivich et al, 2004) . Briefly, mice were anesthetized by intramuscular injection of a combination of xylazine (13 mg/kg) and ketamine HCl (85 mg/kg). The surgical site was shaved and disinfected. A skin incision was made behind the left ear and the facial nerve exposed, and transected about 2 mm posterior to the foramen stylomastoideum as detailed previously. The same incisions were also made on the contralateral side for shamoperated intra-animal controls. The wounds were sutured, and the animals were allowed to recover in a darkened room on isothermal pads warmed at 371C for an estimated 30 min.
Regeneration in facial nuclei in the brainstem following facial nerve transection was evaluated by retrograde axonal tracing with FluoroGold. Three days before being killed, mice from each group were anesthetized and 15 ml of 3% FluoroGold was injected through a micropipette with a tip diameter of 25 mm into the whisker pads bilaterally. After 3 days, the mice were deeply anesthetized and perfused with 0.9% saline solution followed by 4% paraformaldehyde in 0.1 M phosphate buffer. The brain stem was removed and placed in 30% sucrose for 24 h. The entire facial nuclei were sectioned and reconstructed and all sections of both facial nuclei per each animal were evaluated.
Transverse serial frozen sections, 12 mm thick, were cut and mounted on slides, protected by coverslips, and photographed under a fluorescence microscope. Only labeled neurons with visible nuclei were counted and taken to represent the number of regenerated motor neurons. The number of total motor neurons and of regenerating motor neurons in facial nuclei after facial nerve axotomy was studied by counting the number of total cells (cresyl violet stained) and of retrograde labeled motor neurons comparing the uninjured side in each animal for intra-animal control, to the transected side, in both p53 null and WT mice, which resulted in ratio values. Thus, the overall ratio of FluoroGold-positive neurons was compared between mutant and WT animals. The Abercrombie formula for cell counting was included in our analysis to correct for tissue volume.
Supplementary data
Supplementary data are available at The EMBO Journal Online (http://www.embojournal.org).
